Active substanceDextrose + Citric acid + Sodium dihydrogen phosphate + Sodium citrateDextrose + Citric acid + Sodium dihydrogen phosphate + Sodium citrate
Dosage form: & nbsphemoconvant solution
Composition:

Citric acid monohydrate 0.327 g; sodium citrate pentasecylhydrate (sodium citrate for injection) (in terms of sodium citrate) or sodium citrate dihydrate (in terms of sodium citrate) 1,900 g; sodium dihydrogen phosphate dihydrate (sodium phosphate monosubstituted 2-water) 0.251 g; dextrose monohydrate (glucose monohydrate) (in terms of dextrose) 2.550 g; water for injection up to 100 ml.

Description:Colorless or slightly yellowish transparent liquid.
Pharmacotherapeutic group:hemoconvant
ATX: & nbsp

V.07.A.C   Aids for blood transfusion

Pharmacodynamics:

The CFG solution provides an anticoagulant effect by binding calcium cations to citrate anions; In addition, the glucose contained in the preparation serves as a food for blood cells, and phosphate supports the blood buffer system.

The hemoconvant solution is mixed with blood in a ratio of 1 volume to 7 blood volumes.

Indications:

Preservation of donor blood.

Dosing and Administration:

Procurement of blood is carried out in accordance with the "Instruction for the preparation and conservation of donor blood" (approved by the Ministry of Health of the Russian Federation on 29.05.95).

Shelf life of canned blood with CFG is 28 days.

Before use, check the integrity of the consumer container and the tightness of the container.

Form release / dosage:

A solution of hemoconvant.

Packaging:

43 ml or 63 ml is poured into containers:

Single chamber polymer containers for blood:

- 43 ml in a container capacity of 375 ml, 63 ml in a container capacity of 500 ml - "Hemasin".

Two-chamber polymer containers for blood and its components:

- 43 ml in a container capacity of 375 ml (empty container capacity of 300 ml), 63 ml in a container capacity of 500 ml (empty container capacity of 400 ml)

- "Hemasin";

- 63 ml into a container with a capacity of 500 ml (empty container capacity 400 ml).

Three-chamber polymer containers for blood and its components:

- 43 ml in a container capacity of 375 ml (2 empty containers of 300 ml), 63 ml in a container capacity of 500 ml (2 empty container capacity of 400 ml) - "Hemasin";

- 63 ml in a container capacity of 500 ml (2 empty container capacity of 400 ml) - polymer containers for plasmapheresis.

Four-chamber polymer containers for blood and its components:

- 63 ml in a container capacity of 500 ml (2 empty container capacity of 400 ml and one 100 ml each) - "Hemasin";

- on 63 ml in two containers of 500 ml (2 empty container capacity of 400 ml) - "A set of products for non-equipment donor double plasmapheresis once-use sterile - KDP".

On the container with a solution of hemoconvant paste a label of self-adhesive paper.

Each container with a solution of hemoconvant is completed in the product.

The products are packed:

- in three plastic bags: two packages of consumer packaging (inner and outer packages) and one group package; or

- in a polyethylene (inner) bag of polyethylene and a group (outer) bag of a combined multi-layer film based on aluminum foil.

In each group (outer) package of a combined multilayer film based on aluminum foil, insert a sachet of special paper with a latex coating with 10 g of silica gel.

Instructions for medical use of the drug are:

- in a group package - when packing the product in three plastic bags;

- in the transport packaging - when the product is packed in a polyethylene (inner) bag and in a group (outer) package of a combined multilayer film based on aluminum foil,corresponding to the number of group packages with products.

Storage conditions:

In a dry, protected from light and corrosive environments, at a temperature of 5 to 25 ° C.

Freezing during transportation is allowed.

The turbidity of the polymer container and the presence of moisture in the bag with containers, provided that the containers are tight, is not a contraindication to the use of the drug.

Shelf life:

2 years when packing products in three plastic bags.

2,5 years when packing products in a polyethylene bag and a package of a combined film based on aluminum foil.

Do not use at the end of the expiration date printed on the package.

Terms of leave from pharmacies:For hospitals
Registration number:P N002510 / 01
Date of registration:29.01.2009
The owner of the registration certificate:SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products Russia
Manufacturer: & nbsp
Representation: & nbspSYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products SYNTHESIS JSC Joint-Stock Kurgan Society of Medical Preparations and Products Russia
Information update date: & nbsp14.01.2016
Illustrated instructions
    Instructions
    Up